Home » Industry Asks US FDA to Redraft Two Proposed CAD Guidances
Industry Asks US FDA to Redraft Two Proposed CAD Guidances
December 14, 2009
Two draft guidances on computer-assisted detection (CAD) devices are so burdensome that they could kill future innovation by requiring extensive and unnecessary
testing, industry representatives and experts told a U.S. Food and Drug Administration (FDA) advisory panel.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor